|
|
|
|
| Cat. No. 292 015 |
50 µg specific antibody, lyophilized. Affinity purified with the immunogen. Albumin and azide were added for stabilization. For reconstitution add 50 µl H2O to get a 1mg/ml solution in PBS. Then aliquot and store at -20°C to -80°C until use. Antibodies should be stored at +4°C when still lyophilized. Do not freeze! |
| Applications | |
| Immunogen | Full length mouse recombinant Olig2 (UniProt Id: Q9EQW6) |
| Reactivity |
Reacts with: mouse (Q9EQW6), rat (G3V612), human (Q13516). Other species not tested yet. Predicted to cross-react with human (Q13516) due to high sequence homology. |
| Data sheet | 292_015.pdf |
|
|
Olig2 (also known as BHLHB1 and PRKCBP2) is a basic helix–loop–helix transcription factor characteristic of the oligodendroglial lineage and plays key roles in the specification and maturation of oligodendrocytes. Oligodendrocytes are glial cells that produce and maintain central nervous system myelin; Morphologically, oligodendrocyte nuclei are typically smaller and more oval than nuclei of other CNS cell types. (1-3).
In cancer, particularly in diffuse gliomas, Olig2 is widely used as a nuclear immunohistochemical marker of glial lineage. In diagnostic pathology, nuclear Olig2 immunohistochemistry is widely used as a glial lineage marker in diffuse gliomas: Olig2 is strongly expressed in oligodendrogliomas and is also detectable in a substantial proportion of astrocytomas and glioblastomas (GBM). Large cohorts established that Olig2 is highly expressed across diffuse gliomas while being largely restricted to oligodendroglia in normal brain, supporting its utility in routine practice (4, 5).